Wockhardt Share Price
Start SIP in Wockhardt
Start SIPWockhardt Performance
Day Range
- Low 970
- High 1,019
52 Week Range
- Low 213
- High 1,098
- Open Price995
- Previous Close991
- Volume103117
Wockhardt Investment Rating
-
Master Rating:
-
Wockhardt has an operating revenue of Rs. 2,893.00 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of -15% needs improvement, ROE of -13% is poor and needs improvement. The company has a reasonable debt to equity of 27%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 63% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -0% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 37 which is a POOR score indicating inconsistency in earnings, a RS Rating of 94 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 59 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 352 | 355 | 288 | 260 | 251 | 291 |
| Operating Expenses Qtr Cr | 272 | 401 | 263 | 270 | 256 | 321 |
| Operating Profit Qtr Cr | 80 | -46 | 25 | -10 | -5 | -30 |
| Depreciation Qtr Cr | 43 | 45 | 43 | 44 | 44 | 45 |
| Interest Qtr Cr | 58 | 59 | 61 | 59 | 58 | 58 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 10 |
| Net Profit Qtr Cr | 6 | -126 | -74 | -107 | -115 | -299 |
Wockhardt Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 7
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹1,008.05
- 50 Day
- ₹932.49
- 100 Day
- ₹817.80
- 200 Day
- ₹669.74
- 20 Day
- ₹1,028.23
- 50 Day
- ₹941.90
- 100 Day
- ₹768.77
- 200 Day
- ₹629.55
Wockhardt Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 1,016.05 |
| Second Resistance | 1,041.80 |
| Third Resistance | 1,064.80 |
| RSI | 49.48 |
| MFI | 38.47 |
| MACD Single Line | 33.55 |
| MACD | 19.98 |
| Support | |
|---|---|
| First Support | 967.30 |
| Second Support | 944.30 |
| Third Supoort | 918.55 |
Wockhardt Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 129,571 | 12,957,100 | 100 |
| Week | 166,590 | 16,659,040 | 100 |
| 1 Month | 294,582 | 29,458,155 | 100 |
| 6 Month | 520,237 | 36,536,275 | 70.23 |
Wockhardt Result Highlights
Wockhardt Synopsis
NSE-Medical-Generic Drugs
Wockhardt Ltd. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1154.00 Cr. and Equity Capital is Rs. 77.00 Cr. for the Year ended 31/03/2024. Wockhardt Ltd. is a Public Limited Listed company incorporated on 08/07/1999 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1999PLC120720 and registration number is 120720.| Market Cap | 15,198 |
| Sales | 1,255 |
| Shares in Float | 7.36 |
| No of funds | 127 |
| Yield |
| Book Value | 8.5 |
| U/D Vol ratio | 1.1 |
| LTDebt / Equity | 50 |
| Alpha | 0.46 |
| Beta | 1.4 |
Wockhardt Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 51.99% | 51.6% | 54.93% | 55.14% |
| Mutual Funds | 2.91% | 3.11% | 0.09% | 0.03% |
| Insurance Companies | ||||
| Foreign Portfolio Investors | 5.94% | 5.49% | 4.18% | 3.03% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 30.18% | 29.93% | 32.94% | 32.89% |
| Others | 8.98% | 9.87% | 7.86% | 8.91% |
Wockhardt Management
| Name | Designation |
|---|---|
| Dr. Habil Khorakiwala | Founder Chairman |
| Dr. Murtaza Khorakiwala | Managing Director |
| Dr. Huzaifa Khorakiwala | Executive Director |
| Ms. Zahabiya Khorakiwala | Non Executive Director |
| Mrs. Tasneem Mehta | Independent Director |
| Mr. Vinesh Kumar Jairath | Independent Director |
| Mr. Akhilesh Gupta | Independent Director |
| Ms. Amelia Fernandes | Independent Director |
| Mr. Ahmad Javed | Independent Director |
Wockhardt Forecast
Price Estimates
Wockhardt Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-09 | Quarterly Results | |
| 2024-05-28 | Audited Results | |
| 2024-03-26 | Others | Inter alia, to consider and determine the issue price of Equity Shares to be issued pursuant to the Issue, including any discount, not more than 5%, on the floor price. issue of equity shares of Rs. 5/- each in the ratio of 3:10 @ premium of Rs. 220/-. |
| 2024-02-14 | Quarterly Results | |
| 2023-11-14 | Quarterly Results |
Wockhardt FAQs
What is Share Price of Wockhardt ?
Wockhardt share price is ₹990 As on 18 September, 2024 | 02:28
What is the Market Cap of Wockhardt ?
The Market Cap of Wockhardt is ₹15192.1 Cr As on 18 September, 2024 | 02:28
What is the P/E ratio of Wockhardt ?
The P/E ratio of Wockhardt is -44.3 As on 18 September, 2024 | 02:28
What is the PB ratio of Wockhardt ?
The PB ratio of Wockhardt is 4.2 As on 18 September, 2024 | 02:28